World Pharmaceutical Frontiers: Commitment to Excellence
Phillips Medisize was recently featured in World Pharmaceutical Frontiers, discussing our commitment to excellence in the CDMO space for the pharmaceutical industry. Read the article to learn more about how we are driving innovation in this highly demanding and complex field.
Phillips Medisize brings extensive expertise and experience to developing design strategies across every phase of development—from clinical trials through to both small- and large-scale commercial manufacturing. With 23 manufacturing sites and seven R&D innovation centers spread throughout the US, Europe, and Asia, we work closely with pharmaceutical clients worldwide to deliver seamless collaboration and support wherever they are located.